Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
After taking Vik Atopic Dermatitis to 9 countries and in four different languages, our main goal remains guiding patients through their search for a healthier life.
🙌 We are happy to announce the launch of Vik Atopic Dermatitis in Arabic, available in the Kingdom of Saudi Arabia (KSA) and the United Arab Emirates (UAE)! More patients and loved ones can now have access to medically approved content and functionalities and get all the support needed to live better with atopic Dermatitis.
A shout-out to the teams involved in this project 👏 Halim El khoury, Jeremy Busca, Adrien Boher, Guillaume Suiffet, Lucas Tidas, Tristan Voiron, Antonin VAL, Alexandre Josse, Nicolas Laporte, Claire De Giovanni, Jean Bezet, Arthur Guillemassé, Marie Bidault des Chaumes, Marine Daniel, Laisa Lopes, Charlotte Font Armengol, Cynthia Moukarzel, Camélia Ah-Lo, Julie Delorme, Axel Vallée, Cyril Courrée, Arthur Jean-Angèle, Géraud Moustial
Telemedicine at the service of patients 🚀
We’re proud to announce a partnership with TeleClinic, Germany’s market leader for online consultations.
We are proud to announce the launch of Vik Colorectal in Spain! Developed with the institutional support of Pierre Fabre Group, our newest virtual companion will support patients and their loved ones living with colorectal cancer!
It’s with great pleasure that we announce our partnership with Maiia, an e-health solution powered by Cegedim Santé! 💪 Bringing to you the news today, Benoit Brouard, founder and CEO of Wefight, and Victor Jobin, Partnerships Director at Maiia.
Vik Atopic Dermatitis continues its expansion across the world! 🚀 It’s been launched in 3 more countries: the United Arab Emirates, the Kingdom of Saudi Arabia, and Brazil!